Current perspectives in dissolution testing of conventional and novel dosage forms.
about
Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesDevelopment and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.Maize prolamins resistant to peptic-tryptic digestion maintain immune-recognition by IgA from some celiac disease patients.The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.Dissolution testing for generic drugs: an FDA perspective.A nanohybrid system for taste masking of sildenafil.Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluationsTaste Masking of Griseofulvin and Caffeine Anhydrous Using Kleptose Linecaps DE17 by Hot Melt Extrusion.Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.In vitro-in vivo correlation of efavirenz tablets using GastroPlus®Rapidly disintegrating oramucosal drug delivery technologies.Overview of drug product development.A review of formulation techniques that impact the disintegration and mechanical properties of oradispersible drug delivery technologies.Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).Challenges in oral drug delivery in patients with esophageal dysphagia.Application of UV Imaging in Formulation Development.Simulation of in vitro dissolution behavior using DDDPlus™Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.Development and evaluation of buccoadhesive controlled release tablets of lercanidipine.Isothermal microcalorimetry as a quality by design tool to determine optimal blending sequences.Dissolution testing of sublingual tablets: a novel in vitro method.A new drug release method in early development of transdermal drug delivery systems.Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology.Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery.Should digestion assays be used to estimate persistence of potential allergens in tests for safety of novel food proteins?Formulation study of directly compressible chewable polymers containing ascorbic acid.Drug release from semisolid dosage forms: a comparison of two testing methods.Transdermal delivery of salbutamol sulphate: formulation and evaluation.Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol.Determining the suitability of mass spectrometry for understanding the dissolution processes involved with pharmaceutical tablets.Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach.Drug dissolution chip (DDC): a microfluidic approach for drug release.Preparation and in vitro/in vivo evaluation of metformin hydrochloride rectal dosage forms for treatment of patients with type II diabetes.Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy.Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.Electrochemical Behavior of Verapamil at Graphite–Polyurethane Composite Electrodes: Determination of Release Profiles in Pharmaceutical SamplesA Mucoadhesive Electrospun Nanofibrous Matrix for Rapid Oramucosal Drug DeliveryDevelopment and Validation of a Novel RP-HPLC Method for Estimation of Losartan Potassium in Dissolution Samples of Immediate and Sustained Release Tablets
P2860
Q33683206-AB3E81D6-DB31-4A2B-A16C-EDF1DE134F4EQ34570631-68B894FC-A5B7-4787-8B28-4C62057B73F4Q34635585-C12C7E01-AE41-48A7-BC79-7E8E70A83489Q35078360-A2CD13B1-59ED-41F9-8385-8939DAC761CBQ35176894-C090B811-1EF0-41DF-B1FA-3F100B694E6CQ35972590-6EBC91F9-11F8-4A8A-AB06-C090AB9B914DQ35977237-44FA7C8A-9521-444F-8A31-4213A963C001Q36614779-61AE2553-B93D-4A82-9B0F-66D18738150AQ37058658-76A58010-BD50-46F8-B87C-4D1568DF1053Q37126427-D443B5DB-3983-4FB5-BCA1-D65AB4596153Q37626036-8671A5C2-AEF7-4277-A503-39A1324723F7Q37965423-F76EF2C0-426C-4F18-8172-AB3EF3096335Q38308190-A71F2192-8898-4431-A636-9018F50DC108Q38619585-4BDED311-D27E-409F-9366-CA266D195A2DQ38701531-A337EC08-1D71-4EF7-9E8C-04DDC6A315ACQ38808298-6275AEBB-FDDF-4E53-86FF-259032812C62Q41827496-76C3F89C-F0A5-46BA-AC7A-F870562F45F4Q41856899-C8AF724D-B807-4FD2-8192-8492783F9ED7Q41908116-C2207D00-2E90-49B2-987E-F7AF186D96A2Q41987101-31DB20D3-4DF1-4808-97FB-D337F60EBA87Q41988606-7F2C8E11-0159-4A3B-B66E-F8428C865333Q42241071-0D4037A9-EF3E-415C-8EBE-696E1560BB2EQ42276006-F49B32B6-B075-4488-A7D6-34D20682E152Q42705880-8B999D45-6460-472D-89C9-B890F50C5E77Q43191858-7ECF62CB-8F61-4273-8460-A3A94F4E6F18Q44305341-EBCED090-C998-48DB-BC52-044F0C062B12Q45101139-4E33B1C4-38BD-42BC-A6A3-B6F0EB73E0C3Q45973098-80A26743-E118-40D5-AA9F-9EAFB9978D16Q46101248-094459F6-20B3-4160-BEAC-323A6F39CCE5Q46727762-80703E9B-693E-443C-930F-62F5386B8603Q51540613-3806291A-E718-4BB3-ADD0-B21C85E41F5DQ51545938-99D2CD2C-324E-411C-8394-57327D6D4E5CQ53740973-0059B231-B71D-458B-B98E-698DCCC6F80AQ55278388-A500E7CC-2E22-4B1F-BD8D-3AFB9487ED8DQ55341961-35CA3F28-5DE5-4947-B655-CE80746C0F68Q58153905-A7C25A53-CED1-4378-8DD9-5F1662427195Q59019675-DAB63C88-2778-4F7B-A2BC-30B1029EB668Q59036851-85061683-F082-446D-B452-4312FD70F1F4
P2860
Current perspectives in dissolution testing of conventional and novel dosage forms.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Current perspectives in dissolution testing of conventional and novel dosage forms.
@ast
Current perspectives in dissolution testing of conventional and novel dosage forms.
@en
type
label
Current perspectives in dissolution testing of conventional and novel dosage forms.
@ast
Current perspectives in dissolution testing of conventional and novel dosage forms.
@en
prefLabel
Current perspectives in dissolution testing of conventional and novel dosage forms.
@ast
Current perspectives in dissolution testing of conventional and novel dosage forms.
@en
P1476
Current perspectives in dissolution testing of conventional and novel dosage forms
@en
P2093
Shirzad Azarmi
Wilson Roa
P356
10.1016/J.IJPHARM.2006.10.001
P407
P577
2006-10-06T00:00:00Z